FIELD: medicine.
SUBSTANCE: axial myopia is simulated experimentally in chinchillas. The simulation is performed by the daily administration of transretinoic acid 0.3-0.6 ml in the concentration of 0.04-0.07 mg per normal saline 1 ml into the internal carotid artery for 6 months. The administration is performed for 6 months.
EFFECT: method enables providing more accurate reproduction of the pathological process, approaching the simulation to the natural clinical course.
2 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MODELLING MYOPIC EYE DISEASE | 2009 |
|
RU2405502C1 |
| METHOD OF TREATING PROGRESSING MYOPIA IN CHILDREN | 2012 |
|
RU2494708C1 |
| METHOD OF PERITONITIS SIMULATION | 2008 |
|
RU2367029C1 |
| THERAPY OF PROGRESSIVE MYOPIA COMBINED WITH EXTRAOCULAR GASTRODUODENITIS PATHOLOGY | 2008 |
|
RU2358694C1 |
| METHOD FOR PROPHYLAXIS OF CARDIAC ACTIVITY RHYTHM DISORDER | 2005 |
|
RU2283099C1 |
| PHARMACEUTICAL PREPARATION FOR PREVENTION AND TREATMENT OF PROGRESSIVE MYOPIA | 2013 |
|
RU2635185C2 |
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 |
|
RU2684927C1 |
| PROTEIN-PEPTIDE COMPLEX HAVING A PROTECTIVE ACTION ON THE STATE OF TISSUES OF THE POSTERIOR EYE - SCLERAL SHELL, RETINA, PIGMENT EPITHELIUM, CHOROID | 2018 |
|
RU2701566C1 |
| METHOD FOR TREATING PROLIFERATIVE VITREORETINOPATHY USING LIPOSOME-ASSOCIATED MELPHALAN IN AN EXPERIMENT | 2021 |
|
RU2772520C1 |
| DISULFIRAM AND TAURINE-CONTAINING OPHTHALMOLOGICAL MEDICATION IN FORM OF EYE DROPS | 2012 |
|
RU2485939C1 |
